Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.453ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.637.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.79ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XASENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.576ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.521ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.206ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used